In recent days, the Main Pharmaceutical Inspector has announced that more drugs have been withdrawn. We check the latest list of drugs withdrawn by the Main Pharmaceutical Inspectorate. The reasons for such a GIF decision can be varied, from poor packaging of the drug to the wrong composition of the drug. The list of withdrawn drugs by GIF also includes drugs that may be health and even life-threatening. You can no longer buy these drugs in a pharmacy, but it is worth checking if you do not have them in your first aid kit, because some of them have a long expiry date. Below we publish a list of drugs withdrawn by GIF in 2021, their series and the date of production. If in doubt about the usefulness of the medication, consult your doctor or pharmacist.
If, during the conducted checks and tests, there are reasonable suspicions that the medicinal product does not meet the requirements established for it, the authorities of the State Pharmaceutical Inspection issue appropriate decisions:
–
- Voivodship Pharmaceutical Inspector – decision to suspend the marketing of certain batches of a medicinal product in the area of its operations;
- Main Pharmaceutical Inspector – decision to suspend trade of specific batches of a medicinal product throughout the country.
–
After the above decisions are issued, the sale (sale) of the indicated series of a given medicinal product is suspended in all wholesalers and pharmacies, until the results of laboratory tests confirming or excluding a quality defect are obtained.
–
If the results of the tests conducted confirm that the medicinal product does not meet the quality requirements specified for it, the Main Pharmaceutical Inspector shall decide to withdraw the medicinal product from the market. The above decision may also be taken at the request of the responsible entity in connection with its own decision, at the request of the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, if the use of the medicinal product causes a serious undesirable effect, and at the request of the Minister of Health or the President of the Office in the case of possible risk to public health.
–